Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC)

Clinical trial NCT00100685 · TERMINATED

Trial details

NCT number: NCT00100685
Sponsor: Abbott
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Metastases

Start date: 2005-01-01
Primary completion: 2007-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.